{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:58:41Z","timestamp":1778914721926,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad Nacional de Colombia (Direcci\u00f3n de investigaciones de Sede Bogot\u00e1) and School of Medicine","award":["Hermes: 41439"],"award-info":[{"award-number":["Hermes: 41439"]}]},{"name":"Colciencias (Departamento Administrativo de Ciencia), Tecnolog\u00eda e Innovaci\u00f3n","award":["110154531660"],"award-info":[{"award-number":["110154531660"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to determine ANGPTL3 serum levels in healthy young lean and obese non-diabetic men during an oral glucose tolerance test (OGTT) and correlate them with anthropometric, biochemical and hormonal parameters. A case\u2013control study was carried out and 30 young obese non-diabetic (23.90\u2009\u00b1\u20093.84\u00a0years and BMI 37.92\u2009\u00b1\u20094.85\u00a0kg\/m<jats:sup>2<\/jats:sup>) and 28 age-matched healthy lean (24.56\u2009\u00b1\u20093.50\u00a0years and BMI of 22.10\u2009\u00b1\u20091.72\u00a0kg\/m<jats:sup>2<\/jats:sup>) men were included in this study. The primary outcome measures were serum basal ANGPTL3 and ANGPTL3\u2013area under the curve (AUC) levels. The percentage of body fat was measured by dual-energy X-ray absorptiometry and biochemical, hormonal and insulin resistance indices were determined. Basal ANGPTL3 and ANGPTL3\u2013AUC levels were significantly elevated (p\u2009&lt;\u20090.05) in young obese subjects compared with lean subjects and were positively and significantly associated with different anthropometric measurements. Fasting ANGPTL3 serum levels were positively correlated with fasting insulin, leptin, Leptin\/Adiponectin index and triglyceride\u2014glucose index. Moreover, ANGPTL3\u2013AUC was negatively correlated with Matsuda index. In this regard, chronically high ANGPTL3 levels in young obese subjects might favor triglyceride-rich lipoprotein clearance to replenish triglyceride stores by white adipose tissue rather than oxidative tissues.<\/jats:p>","DOI":"10.1038\/s41598-020-77961-8","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T11:02:35Z","timestamp":1606993355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum angiopoietin-like 3 levels are elevated in obese non diabetic men but are unaffected during an oral glucose tolerance test"],"prefix":"10.1038","volume":"10","author":[{"given":"Maria Fernanda","family":"Garc\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julieth Daniela","family":"Buell-Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiver Antonio","family":"Rodr\u00edguez-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefania","family":"Pulido-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Rincon-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Carolina","family":"Moreno-Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Franco-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhoan Sebastian","family":"Roncancio-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro Javier","family":"Burgos-Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Lacunza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Nogueiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Eduardo","family":"Caminos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"77961_CR1","doi-asserted-by":"publisher","first-page":"e008740","DOI":"10.1161\/JAHA.118.008740","volume":"7","author":"PP Toth","year":"2018","unstructured":"Toth, P. P. et al. High triglycerides are associated with increased cardiovascular events, medical costs, and resource use: a real-world administrative claims analysis of statin-treated patients with high residual cardiovascular risk. J. Am. Heart Assoc. 7, e008740 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"77961_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12944-016-0337-x","volume":"15","author":"M Abu-Farha","year":"2016","unstructured":"Abu-Farha, M. et al. Increased ANGPTL3, 4 and ANGPTL8\/betatrophin expression levels in obesity and T2D. Lipids Health Dis. 15, 181 (2016).","journal-title":"Lipids Health Dis."},{"key":"77961_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/ATVBAHA.113.302802","volume":"34","author":"N Mehta","year":"2014","unstructured":"Mehta, N. et al. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler. Thromb. Vasc. Biol. 34, 1057\u20131063 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77961_CR4","volume-title":"Obesity and Overweight","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Obesity and Overweight (WHO, Geneva, 2020)."},{"key":"77961_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","volume":"1841","author":"S Kersten","year":"2014","unstructured":"Kersten, S. Physiological regulation of lipoprotein lipase. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1841, 919\u2013933 (2014).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"77961_CR6","doi-asserted-by":"publisher","first-page":"E271","DOI":"10.1152\/ajpendo.90920.2008","volume":"297","author":"H Wang","year":"2009","unstructured":"Wang, H. & Eckel, R. H. Lipoprotein lipase: from gene to obesity. Am. J. Physiol.-Endocrinol. Metab. 297, E271\u2013E288 (2009).","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"77961_CR7","doi-asserted-by":"publisher","first-page":"150272","DOI":"10.1098\/rsob.150272","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang, R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol. 6, 150272 (2016).","journal-title":"Open Biol."},{"key":"77961_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1194\/jlr.M088807","volume":"60","author":"O Kovrov","year":"2019","unstructured":"Kovrov, O., Kristensen, K. K., Larsson, E., Ploug, M. & Olivecrona, G. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity. J. Lipid Res. 60, 783\u2013793 (2019).","journal-title":"J. Lipid Res."},{"key":"77961_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng814","volume":"30","author":"R Koishi","year":"2002","unstructured":"Koishi, R. et al. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30, 151\u2013157 (2002).","journal-title":"Nat. Genet."},{"key":"77961_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MOL.0000000000000600","volume":"30","author":"S Kersten","year":"2019","unstructured":"Kersten, S. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk. Curr. Opin. Lipidol. 30, 205\u2013211 (2019).","journal-title":"Curr. Opin. Lipidol."},{"key":"77961_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jacl.2017.02.002","volume":"11","author":"R Muniyappa","year":"2017","unstructured":"Muniyappa, R. et al. Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy. J. Clin. Lipidol. 11, 543\u2013550 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"77961_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","volume":"6","author":"X Chi","year":"2017","unstructured":"Chi, X. et al. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol. Metab. 6, 1137\u20131149 (2017).","journal-title":"Mol. Metab."},{"key":"77961_CR13","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbrc.2004.08.024","volume":"322","author":"M Shimamura","year":"2004","unstructured":"Shimamura, M. et al. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem. Biophys. Res. Commun. 322, 1080\u20131085 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77961_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-015-0324-y","volume":"15","author":"HS Chung","year":"2016","unstructured":"Chung, H. S. et al. Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study. Cardiovasc. Diabetol. 15, 1 (2016).","journal-title":"Cardiovasc. Diabetol."},{"key":"77961_CR15","first-page":"203","volume":"35","author":"W Guo","year":"2010","unstructured":"Guo, W., Che, Z., Xu, A. & Zhou, Z. Angiopoietin-like protein 3 and adiponectin levels in patients with metabolic syndrome. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35, 203\u2013208 (2010).","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"77961_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41387-018-0032-2","volume":"8","author":"A Cinkajzlov\u00e1","year":"2018","unstructured":"Cinkajzlov\u00e1, A. et al. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation. Nutr. Diabetes 8, 21 (2018).","journal-title":"Nutr. Diabetes"},{"key":"77961_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.bbrc.2004.03.151","volume":"317","author":"K Inukai","year":"2004","unstructured":"Inukai, K. et al. ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem. Biophys. Res. Commun. 317, 1075\u20131079 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77961_CR18","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","volume":"33","author":"MR Robciuc","year":"2013","unstructured":"Robciuc, M. R. et al. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler. Thromb. Vasc. Biol. 33, 1706\u20131713 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77961_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6578327","volume":"2019","author":"E Christopoulou","year":"2019","unstructured":"Christopoulou, E., Elisaf, M. & Filippatos, T. Effects of angiopoietin-like 3 on triglyceride regulation, glucose homeostasis, and diabetes. Dis. Mark. 2019, 1\u20138 (2019).","journal-title":"Dis. Mark."},{"key":"77961_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/MEG.0b013e32832b77ae","volume":"21","author":"Y Yilmaz","year":"2009","unstructured":"Yilmaz, Y., Ulukaya, E., Atug, O. & Dolar, E. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. Eur. J. Gastroenterol. Hepatol. 21, 1247\u20131251 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"77961_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGM Alberti","year":"2005","unstructured":"Alberti, K. G. M., Zimmet, P. & Shaw, J. The metabolic syndrome\u2014a new worldwide definition. The Lancet 366, 1059\u20131062 (2005).","journal-title":"The Lancet"},{"key":"77961_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.ijo.0803694","volume":"32","author":"MSB Huda","year":"2008","unstructured":"Huda, M. S. B. et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int. J. Obes. 32, 129\u2013135 (2008).","journal-title":"Int. J. Obes."},{"key":"77961_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13340-015-0212-4","volume":"7","author":"K Sakaguchi","year":"2016","unstructured":"Sakaguchi, K. et al. Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance. Diabetol. Int. 7, 53\u201358 (2016).","journal-title":"Diabetol. Int."},{"key":"77961_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato, M. C. et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33, 920\u2013922 (2010).","journal-title":"Diabetes Care"},{"key":"77961_CR25","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/nutd.2011.13","volume":"1","author":"MY Baden","year":"2011","unstructured":"Baden, M. Y. et al. Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities. Nutr. Diabetes 1, e18 (2011).","journal-title":"Nutr. Diabetes"},{"key":"77961_CR26","unstructured":"Mayo Clinic. High Cholesterol (2019). https:\/\/www.mayoclinic.org\/diseases-conditions\/high-blood-cholesterol\/diagnosis-treatment\/drc-20350806."},{"key":"77961_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and\u202f?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"77961_CR28","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462\u20131470 (1999).","journal-title":"Diabetes Care"},{"key":"77961_CR29","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1542\/peds.2004-1921","volume":"115","author":"M Keskin","year":"2005","unstructured":"Keskin, M., Kurtoglu, S., Kendirci, M., Atabek, M. E. & Yazici, C. Homeostasis model assessment is more reliable than the fasting glucose\/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115, e500\u2013e503 (2005).","journal-title":"Pediatrics"},{"key":"77961_CR30","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz, A. et al. Quantitative Insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85, 2402\u20132410 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"77961_CR31","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero, F. et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 95, 3347\u20133351 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"77961_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/jim-2016-000248","volume":"65","author":"MR Salazar","year":"2017","unstructured":"Salazar, M. R. et al. Use of the triglyceride\/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity?. J. Investig. Med. 65, 323\u2013327 (2017).","journal-title":"J. Investig. Med."},{"key":"77961_CR33","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00125-009-1508-3","volume":"52","author":"FM Finucane","year":"2009","unstructured":"Finucane, F. M. et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52, 2345\u20132349 (2009).","journal-title":"Diabetologia"},{"key":"77961_CR34","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1161\/CIRCRESAHA.115.305937","volume":"116","author":"CM Kusminski","year":"2015","unstructured":"Kusminski, C. M. & Scherer, P. E. Leptin beyond the lipostat: key component of blood pressure regulation. Circ. Res. 116, 1293\u20131295 (2015).","journal-title":"Circ. Res."},{"key":"77961_CR35","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2020)."},{"key":"77961_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber, W. et al. Orchestrating high-throughput genomic analysis with bioconductor. Nat. Methods 12, 115\u2013121 (2015).","journal-title":"Nat. Methods"},{"key":"77961_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0006-291X(02)03058-9","volume":"301","author":"M Shimamura","year":"2003","unstructured":"Shimamura, M. et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem. Biophys. Res. Commun. 301, 604\u2013609 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77961_CR38","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1194\/jlr.M002618","volume":"51","author":"MR Robciuc","year":"2010","unstructured":"Robciuc, M. R., Tahvanainen, E., Jauhiainen, M. & Ehnholm, C. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J. Lipid Res. 51, 824\u2013831 (2010).","journal-title":"J. Lipid Res."},{"key":"77961_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7555\/JBR.32.20170114","volume":"33","author":"P Tarugi","year":"2019","unstructured":"Tarugi, P., Bertolini, S. & Calandra, S. Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia. J. Biomed. Res. 33, 73\u201381 (2019).","journal-title":"J. Biomed. Res."},{"key":"77961_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.76","volume":"40","author":"CJ Willer","year":"2008","unstructured":"Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161\u2013169 (2008).","journal-title":"Nat. Genet."},{"key":"77961_CR41","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","volume":"363","author":"K Musunuru","year":"2010","unstructured":"Musunuru, K. et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363, 2220\u20132227 (2010).","journal-title":"N. Engl. J. Med."},{"key":"77961_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37118","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Investig. https:\/\/doi.org\/10.1172\/JCI37118 (2008).","journal-title":"J. Clin. Investig."},{"key":"77961_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cca.2011.11.020","volume":"413","author":"JM Mart\u00edn-Campos","year":"2012","unstructured":"Mart\u00edn-Campos, J. M. et al. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation. Clin. Chim. Acta 413, 552\u2013555 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"77961_CR44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/ATVBAHA.111.238766","volume":"32","author":"D Noto","year":"2012","unstructured":"Noto, D. et al. Prevalence of ANGPTL3 and APOB gene mutations in subjects with Combined Hypolipidemia. Arterioscler. Thromb. Vasc. Biol. 32, 805\u2013809 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77961_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCGENETICS.111.960674","volume":"5","author":"L Pisciotta","year":"2012","unstructured":"Pisciotta, L. et al. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Circ. Cardiovasc. Genet. 5, 42\u201350 (2012).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"77961_CR46","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacbts.2019.05.008","volume":"4","author":"X Wang","year":"2019","unstructured":"Wang, X. & Musunuru, K. Angiopoietin-like 3 from discovery to therapeutic gene editing. JACC Basic Transl. Sci. 4, 755\u2013762 (2019).","journal-title":"JACC Basic Transl. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77961-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77961-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77961-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T14:09:36Z","timestamp":1697292576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77961-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77961"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77961-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21118"}}